A carregar...
Auranofin Suppresses Plasminogen Activator Inhibitor-2 Expression through Annexin A5 Induction in Human Prostate Cancer Cells
Auranofin has been developed as antirheumatic drugs, which is currently under clinical development for the treatment of chronic lymphocytic leukemia. Previous report showed that auranofin induced apoptosis by enhancement of annexin A5 expression in PC-3 cells. To understand the role of annexin A5 in...
Na minha lista:
| Publicado no: | Biomol Ther (Seoul) |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
The Korean Society of Applied Pharmacology
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5340543/ https://ncbi.nlm.nih.gov/pubmed/27956714 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4062/biomolther.2016.223 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|